Solventum Corp

SOLV's break below key horizontal support at $87.45 on elevated volume signals a medium-term bearish continuation, but short-term price is extended below the 9- and 20-day EMAs without a pullback into the former support zone. Execution is deferred—monitor for a rebound toward the broken support area and dynamic EMA resistance to sell with better conviction. The longer-term uptrend remains intact above the 200-day SMA, anchoring structural context.

• ↑Q2 revenue $2.2B (+9.5% organic YoY) with EPS $2.55 beating estimates
• ↑HIS business separation to sharpen focus on MedSurg and dental
• ↓Negative growth revisions signal slowing top-line momentum ahead